The experimental disease models included a broad range of conditions, such as diet-induced obesity and insulin resistance, NAFLD, leptin-deficient insulin resistance, and chronic vascular endothelial dysfunction. Here, LEP is linked to metabolic dysfunction-associated steatotic liver disease.